Cardiff Oncology Inc. (CRDF)
NASDAQ: CRDF
· Real-Time Price · USD
2.44
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
2.47
1.44%
After-hours: Aug 15, 2025, 07:52 PM EDT
Cardiff Oncology Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 10.78M | 24.09M | 51.47M | 13.04M | 25.5M | 18.66M | 21.66M | 15.23M | 19.37M | 15.02M | 16.35M | 18.72M | 20.96M | 20.05M | 11.94M | 13.16M | 10.58M | 14.66M |
Short-Term Investments | 60.17M | 55.79M | 40.28M | 44.63M | 34.82M | 48.53M | 53.17M | 66.13M | 70.06M | 81.95M | 88.92M | 95.59M | 101.04M | 109.31M | 128.88M | 120.88M | 129.47M | 110.92M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 139K | n/a | n/a | n/a |
Other Long-Term Assets | 401K | 257K | 69K | 1.27M | 1.27M | 1.27M | 1.28M | 1.39M | 1.39M | 1.36M | 1.39M | 184K | 185K | 188K | 100K | 143K | 263K | 238K |
Receivables | 526K | 405K | 773K | 618K | 451K | 393K | 288K | 198K | 161K | 676K | 771K | 650K | 551K | 447K | 535K | 395K | 308K | 242K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.21M | 2.42M | 2.54M | 1.05M | 1.48M | 2.41M | 2.3M | 2.34M | 3.14M | 4.11M | 5.25M | 4.8M | 4.86M | 6M | n/a | 3.33M | 2.51M | 2.74M |
Total Current Assets | 73.7M | 82.71M | 95.05M | 59.33M | 62.25M | 69.99M | 77.41M | 83.91M | 92.73M | 101.75M | 111.28M | 119.75M | 127.41M | 135.81M | 146.13M | 137.77M | 142.87M | 128.57M |
Property-Plant & Equipment | 1.64M | 1.84M | 2.07M | 2.3M | 2.53M | 2.77M | 2.95M | 3.16M | 3.33M | 3.44M | 3.52M | 3.69M | 3.66M | 3.21M | 3.18M | 3.4M | 600K | 765K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.04M | 2.1M | 2.14M | 3.56M | 3.81M | 4.05M | 4.22M | 4.55M | 4.72M | 4.8M | 4.91M | 3.88M | 3.85M | 3.4M | 3.42M | 3.54M | 863K | 1M |
Total Assets | 75.74M | 84.81M | 97.19M | 62.9M | 66.05M | 74.04M | 81.64M | 88.45M | 97.45M | 106.55M | 116.19M | 123.63M | 131.26M | 139.2M | 149.54M | 141.31M | 143.73M | 129.57M |
Account Payables | 6.01M | 3.63M | 4.82M | 4.64M | 5.11M | 5.19M | 1.97M | 2.18M | 2.94M | 2.91M | 1.96M | 1.43M | 1.52M | 1.26M | 1.44M | 396K | 543K | 803K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.53M | 4.01M | 3.59M | 3M |
Short-Term Debt | 721K | n/a | n/a | n/a | 702K | n/a | 691K | 688K | 683K | 679K | n/a | 674K | 670K | 665K | n/a | 594K | 402K | 635K |
Other Current Liabilities | 9.94M | 1.3M | 2.75M | 7.17M | 4.22M | n/a | 4.36M | 3.01M | 2.64M | 2.89M | n/a | 5.35M | 5.5M | 213K | 456K | -552K | -360K | -593K |
Total Current Liabilities | 16.67M | 13.29M | 13.43M | 12.53M | 12.52M | 11.84M | 10.44M | 9.02M | 9.12M | 8.15M | 7.81M | 8.24M | 8.48M | 6.66M | 6.56M | 5.04M | 4.58M | 4.48M |
Long-Term Debt | 464K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 35K | 231K | 269K |
Total Long-Term Liabilities | 464K | 640K | 813K | 979K | 1.14M | 1.3M | 1.46M | 1.61M | 1.75M | 1.9M | 2.04M | 2.17M | 2.31M | 2.44M | 2.57M | 2.73M | 237K | 277K |
Total Liabilities | 17.13M | 13.93M | 14.24M | 13.5M | 13.66M | 13.14M | 11.9M | 10.63M | 10.88M | 10.05M | 9.85M | 10.42M | 10.79M | 9.1M | 9.13M | 7.77M | 4.82M | 4.76M |
Total Debt | 1.19M | 1.36M | 1.52M | 1.69M | 1.84M | 2M | 2.15M | 2.29M | 2.44M | 2.58M | 2.71M | 2.85M | 2.98M | 3.1M | 3.12M | 3.29M | 408K | 643K |
Common Stock | 7K | 7K | 7K | 5K | 5K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
Retained Earnings | -411.56M | -397.61M | -384.18M | -372.39M | -360.54M | -348.76M | -339.54M | -330.2M | -320.47M | -309.32M | -298.1M | -289.83M | -281.26M | -270.81M | -259.81M | -250.36M | -243.44M | -236.68M |
Comprehensive Income | n/a | 27K | 34K | 82K | -97K | -132K | -67K | -407K | -431K | -76K | -395K | -779K | -982K | -748K | -142K | 16K | -10K | -67K |
Shareholders Equity | 58.61M | 70.88M | 82.95M | 49.39M | 52.39M | 60.89M | 69.74M | 77.83M | 86.58M | 96.5M | 106.34M | 113.21M | 120.47M | 130.1M | 140.42M | 133.54M | 138.92M | 124.82M |
Total Investments | n/a | 55.79M | 40.28M | 44.63M | 34.82M | 48.53M | 53.17M | 66.13M | 70.06M | 81.95M | 88.92M | 95.59M | 101.04M | 109.31M | 128.88M | 120.88M | 129.47M | 110.92M |